Nath Bio-Genes (India) Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Operating Revenue	4,451	3,649	3,326	3,014	2,784
Other Revenue	-	1.31	1.41	-	-
Revenue	4,451	3,650	3,328	3,014	2,784
Revenue Growth (YoY)	21.93%	9.70%	10.42%	8.26%	-9.49%
Cost of Revenue	2,015	902.49	903.04	814.33	936.65
Gross Profit	2,436	2,748	2,425	2,199	1,847
Selling, General & Admin	1,582	522.24	442.11	372.48	382.11
Other Operating Expenses	329.34	1,716	1,482	1,338	1,088
Operating Expenses	1,951	2,276	1,957	1,741	1,501
Operating Income	484.75	471.49	467.6	458.79	345.7
Interest Expense	-159.58	-99	-86.29	-95.73	-101.25
Interest & Investment Income	-	35.89	3.23	0.18	10.93
Currency Exchange Gain (Loss)	-	6.4	-0.14	4.3	0.59
Other Non Operating Income (Expenses)	77.8	-4.39	-3.26	-5.93	-3.88
EBT Excluding Unusual Items	402.96	410.38	381.15	361.59	252.08
Gain (Loss) on Sale of Assets	-	-10.35	0.01	-0.01	0.04
Other Unusual Items	60.07	5.4	34.49	-	-887.82
Pretax Income	463.04	405.84	415.65	361.64	-634.34
Income Tax Expense	46.73	19.85	19.46	11.53	39.52
Net Income	416.3	386	396.19	350.11	-673.85
Net Income to Common	416.3	386	396.19	350.11	-673.85
Net Income Growth	7.85%	-2.57%	13.16%	-	-
Shares Outstanding (Basic)	20	19	19	19	19
Shares Outstanding (Diluted)	20	19	19	19	19
Shares Change (YoY)	4.41%	-	-	-	-
EPS (Basic)	20.98	20.31	20.85	18.42	-35.46
EPS (Diluted)	20.98	20.31	20.85	18.42	-35.46
EPS Growth	3.29%	-2.57%	13.16%	-	-
Free Cash Flow	-155.78	96.61	478.18	354.85	-39.56
Free Cash Flow Per Share	-7.85	5.08	25.16	18.67	-2.08
Dividend Per Share	2.000	2.000	2.000	2.000	2.000
Gross Margin	54.73%	75.28%	72.86%	72.98%	66.35%
Operating Margin	10.89%	12.92%	14.05%	15.22%	12.42%
Profit Margin	9.35%	10.57%	11.91%	11.62%	-24.21%
Free Cash Flow Margin	-3.50%	2.65%	14.37%	11.77%	-1.42%
EBITDA	524.39	509.32	500.21	488.91	376.54
EBITDA Margin	11.78%	13.95%	15.03%	16.22%	13.53%
D&A For EBITDA	39.64	37.83	32.61	30.12	30.84
EBIT	484.75	471.49	467.6	458.79	345.7
EBIT Margin	10.89%	12.92%	14.05%	15.22%	12.42%
Effective Tax Rate	10.09%	4.89%	4.68%	3.19%	-
Revenue as Reported	4,451	3,695	3,333	3,019	2,802
Advertising Expenses	-	48.31	50.51	37.04	16.34

Source: S&P Global Market Intelligence. Standard template. Financial Sources.